The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: n n n n n n n n n n where A, B, W 1 , W 2 , W 3 , and R 1 -R 8 are described herein.